Bristol-Myers Squibb Co.
Symbol: BMY (NYSE)
44.72
▲ (0.12%) 0.055
Company Description:
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Key Stats
- Today's Open: $44.74
- Today's High: $44.886
- Today's Low: $44.464
- Today's Volume: 5.92M
- Yesterday Close: $44.66
- Yesterday High: $45.17
- Yesterday Low: $44.25
- Yesterday Volume: 13.02M
- Last Min Volume: 20.72K
- Last Min High: $44.725
- Last Min Low: $44.705
- Last Min VWAP: $44.71346
Company Profile
- Name: Bristol-Myers Squibb Co.
- Website: https://www.bms.com
- Listed Date: 1952-06-23
- Location: PRINCETON, NJ
- Market Status: Active
- CIK Number: 0000014272
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $90.90B
- Round Lot: 100
- Outstanding Shares: 2.04B
- Asset Type: CS
RECENT FILINGS FOR BMY
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-06 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-03 | 4 | View |
| 2025-09-02 | 144 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 3 | View |
| 2025-08-05 | 4 | View |
| 2025-08-05 | 4 | View |
| 2025-07-31 | 10-Q | View |
| 2025-07-31 | 8-K | View |
| 2025-07-25 | 8-K | View |
| 2025-07-02 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
Latest News on BMY